COST-EFFECTIVENESS ANALYSIS OF OCTREOTIDE LAR VERSUS LANREOTIDE SR FOR THE TREATMENT OF PATIENTS WITH ACTIVE ACROMEGALY IN CHINA
Abstract
Authors
J. Xuan Z. Zhang Y. Wang Z. Mao Y.J. Lu R. Wang
J. Xuan Z. Zhang Y. Wang Z. Mao Y.J. Lu R. Wang
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now